29 related articles for article (PubMed ID: 19546527)
1. TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.
Kinashi H; Ito Y; Mizuno M; Suzuki Y; Terabayashi T; Nagura F; Hattori R; Matsukawa Y; Mizuno T; Noda Y; Nishimura H; Nishio R; Maruyama S; Imai E; Matsuo S; Takei Y
J Am Soc Nephrol; 2013 Oct; 24(10):1627-42. PubMed ID: 23990681
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-β induced Warburg-like metabolic reprogramming may underpin the development of peritoneal endometriosis.
Young VJ; Brown JK; Maybin J; Saunders PT; Duncan WC; Horne AW
J Clin Endocrinol Metab; 2014 Sep; 99(9):3450-9. PubMed ID: 24796928
[TBL] [Abstract][Full Text] [Related]
3. D-limonene inhibits peritoneal adhesion formation in rats via anti-inflammatory, anti-angiogenic, and antioxidative effects.
Razazi A; Kakanezhadi A; Raisi A; Pedram B; Dezfoulian O; Davoodi F
Inflammopharmacology; 2024 Apr; 32(2):1077-1089. PubMed ID: 38308792
[TBL] [Abstract][Full Text] [Related]
4. Baxter Physioneal, Extraneal, Nutrineal (PEN) and Dianeal solution bags can be accidentally connected to Fresenius peritoneal dialysis catheter extensions in a non-sterile manner.
Albert A; Richter S; Woitas RP; Hinkel UP; Stieger P; Braun-Dullaeus RC; Albert C
Clin Kidney J; 2024 Apr; 17(4):sfae067. PubMed ID: 38618491
[No Abstract] [Full Text] [Related]
5. Low molecular weight heparin (LMWH) improves peritoneal function and inhibits peritoneal fibrosis possibly through suppression of HIF-1α, VEGF and TGF-β1.
Li J; Guo ZY; Gao XH; Bian Q; Jia M; Lai XL; Wang TY; Bian XL; Wang HY
PLoS One; 2015; 10(2):e0118481. PubMed ID: 25723475
[TBL] [Abstract][Full Text] [Related]
6. Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions.
Pletinck A; Vanholder R; Veys N; Van Biesen W
Nat Rev Nephrol; 2012 Sep; 8(9):542-50. PubMed ID: 22777203
[TBL] [Abstract][Full Text] [Related]
7. Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.
Mallipattu SK; He JC; Uribarri J
Semin Dial; 2012; 25(5):529-38. PubMed ID: 22548330
[TBL] [Abstract][Full Text] [Related]
8. An update on RAAS blockade and peritoneal membrane preservation: the ace of art.
Wontanatawatot W; Eiam-Ong S; Leelahavanichkul A; Kanjanabuch T
J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S175-83. PubMed ID: 22043587
[TBL] [Abstract][Full Text] [Related]
9. Update on mechanisms of ultrafiltration failure.
Kim YL
Perit Dial Int; 2009 Feb; 29 Suppl 2():S123-7. PubMed ID: 19270200
[TBL] [Abstract][Full Text] [Related]
10. Effects of new peritoneal dialysis solutions, pyridoxamine and AT1 receptor blocker, on TGF-beta1 and VEGF expression in rat peritoneal mesothelial cells.
Mizuiri S; Ohashi Y; Hemmi H; Arita M; Yamada K; Aoki T; Miyagi M; Sakai K; Aikawa A
Am J Nephrol; 2009; 30(3):295-302. PubMed ID: 19546527
[TBL] [Abstract][Full Text] [Related]
11. Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells.
Ha H; Cha MK; Choi HN; Lee HB
Perit Dial Int; 2002; 22(2):171-7. PubMed ID: 11990400
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
13. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor.
Aroeira LS; Aguilera A; Selgas R; Ramírez-Huesca M; Pérez-Lozano ML; Cirugeda A; Bajo MA; del Peso G; Sánchez-Tomero JA; Jiménez-Heffernan JA; López-Cabrera M
Am J Kidney Dis; 2005 Nov; 46(5):938-48. PubMed ID: 16253736
[TBL] [Abstract][Full Text] [Related]
15. Connective tissue growth factor knockdown attenuated matrix protein production and vascular endothelial growth factor expression induced by transforming growth factor-beta1 in cultured human peritoneal mesothelial cells.
Xiao L; Sun L; Liu FY; Peng YM; Duan SB
Ther Apher Dial; 2010 Feb; 14(1):27-34. PubMed ID: 20438517
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
